talquetamab
Talquetamab is a drug used to treat Multiple Myeloma and Hematological Malignancies. Talquetamab is being actively studied in 6 studies; no studies for this drug have been completed so far.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Janssen Research & Development, LLC | Clinica Univ. de Navarra | |
Janssen Pharmaceutical K.K. | Hosp. Clinico Univ. de Salamanca | |
Hosp. Univ. Fund. Jimenez Diaz |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
Recruiting
- Multiple Myeloma
- Talquetamab
- +2 more
- Edmonton, Alberta, Canada
- +12 more
2022-03-24
Mar 24, 2022J
Recruiting
- Hematological Malignancies
- Talquetamab
- Birmingham, Alabama
- +14 more
2022-03-24
Mar 24, 2022J
Recruiting
- Multiple Myeloma
- Talquetamab
- +4 more
- Birmingham, Alabama
- +33 more
2022-03-24
Mar 24, 2022J
Recruiting
- Multiple Myeloma
- Talquetamab
- Kamakura-shi, Japan
- +5 more
2022-03-24
Mar 24, 2022J
J
Recruiting
- Hematological Malignancies
- Talquetamab
- Birmingham, Alabama
- +77 more
2022-03-24
Mar 24, 2022